ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Jin Xu
Matched on ORCID iD 0000-0002-5342-2341; OpenAlex author ID A5100380904. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 21
2025: 3 papers
Papers 3
- A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancer. Co-author DOI 10.1016/j.xcrm.2025.102364↗
- m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis. Last author DOI 10.1038/s41419-025-08049-2↗
- Stromal Stiffness-Regulated IGF2BP2 in Pancreatic Cancer Drives Immune Evasion via Sphingomyelin Metabolism. Co-author DOI 10.1053/j.gastro.2025.03.019↗
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xianjun Yu · 3 shared papers, 2025 · strength 0.61
- Paper m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediat… DOI 10.1038/s41419-025-08049-2↗
- Paper A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metasta… DOI 10.1016/j.xcrm.2025.102364↗
- Paper Stromal Stiffness-Regulated IGF2BP2 in Pancreatic Cancer Drives Immune Evasion via Sphingomyelin Metabolism. DOI 10.1053/j.gastro.2025.03.019↗
- Zhen Tan · 2 shared papers, 2025 · strength 0.41
- Paper m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediat… DOI 10.1038/s41419-025-08049-2↗
- Paper Stromal Stiffness-Regulated IGF2BP2 in Pancreatic Cancer Drives Immune Evasion via Sphingomyelin Metabolism. DOI 10.1053/j.gastro.2025.03.019↗
- Mingming Xiao · 2 shared papers, 2025 · strength 0.41
- Paper m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediat… DOI 10.1038/s41419-025-08049-2↗
- Paper Stromal Stiffness-Regulated IGF2BP2 in Pancreatic Cancer Drives Immune Evasion via Sphingomyelin Metabolism. DOI 10.1053/j.gastro.2025.03.019↗
- Zeyin Rong · 2 shared papers, 2025 · strength 0.41
- Paper m6A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediat… DOI 10.1038/s41419-025-08049-2↗
- Paper Stromal Stiffness-Regulated IGF2BP2 in Pancreatic Cancer Drives Immune Evasion via Sphingomyelin Metabolism. DOI 10.1053/j.gastro.2025.03.019↗
- Si Shi · 2 shared papers, 2025 · strength 0.38
- Paper A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metasta… DOI 10.1016/j.xcrm.2025.102364↗
- Paper Stromal Stiffness-Regulated IGF2BP2 in Pancreatic Cancer Drives Immune Evasion via Sphingomyelin Metabolism. DOI 10.1053/j.gastro.2025.03.019↗
- Heng Zhu · 1 shared paper, 2025 · strength 0.22
- Qingcai Meng · 1 shared paper, 2025 · strength 0.22
- Rong Tang · 1 shared paper, 2025 · strength 0.22
- Xiaomeng Liu · 1 shared paper, 2025 · strength 0.22
- Xu He · 1 shared paper, 2025 · strength 0.22
- Jianhui Yang · 1 shared paper, 2025 · strength 0.22
- Chen Liang · 1 shared paper, 2025 · strength 0.22
- Miaoyan Wei · 1 shared paper, 2025 · strength 0.20
- Wei Wang · 1 shared paper, 2025 · strength 0.20
- Chen Liu · 1 shared paper, 2025 · strength 0.20
- Xiaowu Xu · 1 shared paper, 2025 · strength 0.20
- Rong Tang · 1 shared paper, 2025 · strength 0.19
- Yingna Liao · 1 shared paper, 2025 · strength 0.19
- Qiong Du · 1 shared paper, 2025 · strength 0.19
- Wei Wang · 1 shared paper, 2025 · strength 0.19
- Siyuan Lu · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.